HealthEquity Announces CTO Departure, Appoints Internal Successor

summarizeSummary

HealthEquity's Chief Technology Officer, Eli Rosner, will depart, with Executive Vice President Sunil Rajasekar assuming oversight of the technology organization.

check_boxKey Events

• Chief Technology Officer Departs

  Eli Rosner's employment as Chief Technology Officer will be terminated by the Company without cause, effective April 17, 2026.

• Internal Succession Plan

  Sunil Rajasekar, the Company's Executive Vice President, Chief Product and Strategy Officer, will oversee the technology organization.

• Severance and Equity Treatment

  Mr. Rosner will receive previously negotiated severance payments and benefits, with outstanding equity awards treated consistent with existing plan terms.

• Successor's Extensive Experience

  Sunil Rajasekar has served as EVP, Chief Product and Strategy Officer since January 2026, and previously held CEO and President roles at other technology companies.

auto_awesomeAnalysis

HealthEquity announced the termination of its Chief Technology Officer, Eli Rosner, without cause. While any C-suite departure introduces a degree of uncertainty, the company has a clear succession plan in place. Sunil Rajasekar, the current Executive Vice President, Chief Product and Strategy Officer, will assume oversight of the technology organization. Mr. Rajasekar brings significant leadership experience, including prior CEO and President roles, which helps mitigate potential concerns regarding the transition. Investors should monitor future strategic technology initiatives under the new leadership.